Literature DB >> 22733568

Cellular ageing, increased mortality and FTLD-TDP-associated neuropathology in progranulin knockout mice.

Hans Wils1, Gernot Kleinberger, Sandra Pereson, Jonathan Janssens, Anja Capell, Debby Van Dam, Ivy Cuijt, Geert Joris, Peter P De Deyn, Christian Haass, Christine Van Broeckhoven, Samir Kumar-Singh.   

Abstract

Loss-of-function mutations in progranulin (GRN) are associated with frontotemporal lobar degeneration with intraneuronal ubiquitinated protein accumulations composed primarily of hyperphosphorylated TDP-43 (FTLD-TDP). The mechanism by which GRN deficiency causes TDP-43 pathology or neurodegeneration remains elusive. To explore the role of GRN in vivo, we established Grn knockout mice using a targeted genomic recombination approach and Cre-LoxP technology. Constitutive Grn homozygous knockout (Grn(-/-) ) mice were born in an expected Mendelian pattern of inheritance and showed no phenotypic alterations compared to heterozygous (Grn(+/-) ) or wild-type (Wt) littermates until 10 months of age. From then, Grn(-/-) mice showed reduced survival accompanied by significantly increased gliosis and ubiquitin-positive accumulations in the cortex, hippocampus, and subcortical regions. Although phosphorylated TDP-43 could not be detected in the ubiquitinated inclusions, elevated levels of hyperphosphorylated full-length TDP-43 were recovered from detergent-insoluble brain fractions of Grn(-/-) mice. Phosphorylated TDP-43 increased with age and was primarily extracted from the nuclear fraction. Grn(-/-) mice also showed degenerative liver changes and cathepsin D-positive foamy histiocytes within sinusoids, suggesting widespread defects in lysosomal turnover. An increase in insulin-like growth factor (IGF)-1 was observed in Grn(-/-) brains, and increased IGF-1 signalling has been associated with decreased longevity. Our data suggest that progranulin deficiency in mice leads to reduced survival in adulthood and increased cellular ageing accompanied by hyperphosphorylation of TDP-43, and recapitulates key aspects of FTLD-TDP neuropathology.
Copyright © 2012 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22733568     DOI: 10.1002/path.4043

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  61 in total

1.  PGRN induces impaired insulin sensitivity and defective autophagy in hepatic insulin resistance.

Authors:  Jiali Liu; Huixia Li; Bo Zhou; Lin Xu; Xiaomin Kang; Wei Yang; Shufang Wu; Hongzhi Sun
Journal:  Mol Endocrinol       Date:  2015-02-09

Review 2.  Potential roles of microglial cell progranulin in HIV-associated CNS pathologies and neurocognitive impairment.

Authors:  Hyeon-Sook Suh; Benjamin B Gelman; Sunhee C Lee
Journal:  J Neuroimmune Pharmacol       Date:  2014-03       Impact factor: 4.147

Review 3.  FTD and ALS--translating mouse studies into clinical trials.

Authors:  Lars M Ittner; Glenda M Halliday; Jillian J Kril; Jürgen Götz; John R Hodges; Matthew C Kiernan
Journal:  Nat Rev Neurol       Date:  2015-05-05       Impact factor: 42.937

4.  Opposing effects of progranulin deficiency on amyloid and tau pathologies via microglial TYROBP network.

Authors:  Hideyuki Takahashi; Zoe A Klein; Sarah M Bhagat; Adam C Kaufman; Mikhail A Kostylev; Tsuneya Ikezu; Stephen M Strittmatter
Journal:  Acta Neuropathol       Date:  2017-01-09       Impact factor: 17.088

5.  Progranulin Stimulates the In Vitro Maturation of Pro-Cathepsin D at Acidic pH.

Authors:  Victoria J Butler; Wilian A Cortopassi; Andrea R Argouarch; Sam L Ivry; Charles S Craik; Matthew P Jacobson; Aimee W Kao
Journal:  J Mol Biol       Date:  2019-01-25       Impact factor: 5.469

6.  Establishment of a surgically-induced model in mice to investigate the protective role of progranulin in osteoarthritis.

Authors:  Yunpeng Zhao; Ben Liu; Chuan-ju Liu
Journal:  J Vis Exp       Date:  2014-02-25       Impact factor: 1.355

7.  Opposite microglial activation stages upon loss of PGRN or TREM2 result in reduced cerebral glucose metabolism.

Authors:  Julia K Götzl; Matthias Brendel; Georg Werner; Samira Parhizkar; Laura Sebastian Monasor; Gernot Kleinberger; Alessio-Vittorio Colombo; Maximilian Deussing; Matias Wagner; Juliane Winkelmann; Janine Diehl-Schmid; Johannes Levin; Katrin Fellerer; Anika Reifschneider; Sebastian Bultmann; Peter Bartenstein; Axel Rominger; Sabina Tahirovic; Scott T Smith; Charlotte Madore; Oleg Butovsky; Anja Capell; Christian Haass
Journal:  EMBO Mol Med       Date:  2019-06       Impact factor: 12.137

8.  The Lysosomal Trafficking Transmembrane Protein 106B Is Linked to Cell Death.

Authors:  Hiroaki Suzuki; Masaaki Matsuoka
Journal:  J Biol Chem       Date:  2016-08-25       Impact factor: 5.157

9.  Progranulin Gene Therapy Improves Lysosomal Dysfunction and Microglial Pathology Associated with Frontotemporal Dementia and Neuronal Ceroid Lipofuscinosis.

Authors:  Andrew E Arrant; Vincent C Onyilo; Daniel E Unger; Erik D Roberson
Journal:  J Neurosci       Date:  2018-01-29       Impact factor: 6.167

Review 10.  Neuronal ceroid lipofuscinosis: impact of recent genetic advances and expansion of the clinicopathologic spectrum.

Authors:  Susan L Cotman; Amel Karaa; John F Staropoli; Katherine B Sims
Journal:  Curr Neurol Neurosci Rep       Date:  2013-08       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.